Digital Content 
NEWS #PharmaBuzz
30 Aug 2024
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-lifesciences-gets-usfda-nod-to-market-scopolamine-transdermal-system/articleshow/112925108.cms
29 Aug 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217893
31 Jan 2024
// Kevin Dunleavy FIERCE PHARMA
https://www.fiercepharma.com/pharma/fda-rejects-defenders-motion-sickness-nasal-gel-candidate#:~:text=A%20nasal%20gel%20version%20of%20the%20motion%20sickness%20drug%20scopolamine,and%20vomiting%20induced%20by%20motion.
30 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/01/30/2820312/0/en/Defender-Pharmaceuticals-Receives-Complete-Response-Letter-from-the-U-S-Food-and-Drug-Administration-for-its-Intranasal-Scopolamine-DPI-386-New-Drug-Application-for-the-Prevention-.html
26 Sep 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/09/26/2749419/0/en/FDA-Accepts-Defender-Pharmaceuticals-New-Drug-Application-for-Intranasal-Scopolamine-Gel.html
26 Jul 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/07/26/2711490/0/en/Defender-Pharmaceuticals-Announces-Submission-of-New-Drug-Application-to-FDA-with-Intranasal-Scopolamine-for-Prevention-of-Nausea-and-Vomiting-Induced-by-Motion-in-Adults.html
LOOKING FOR A SUPPLIER?
Share